Related Experiment Videos
Bromhexine in the treatment of otitis media with effusion
Insights
This study found bromhexine hydrochloride did not effectively treat otitis media with effusion (OME) in children. The resolution rates for bromhexine and placebo were similar, indicating it is not a useful drug for OME.
Area of Science:
- Pediatric Otolaryngology
- Pharmacological Research
- Clinical Trials
Background:
- Otitis media with effusion (OME) is a common condition in children.
- Effective treatments for OME are crucial to prevent long-term complications.
- Mucolytic agents are sometimes considered for OME management.
Purpose of the Study:
- To evaluate the efficacy of bromhexine hydrochloride in treating OME in children.
- To compare bromhexine hydrochloride's effectiveness against a placebo.
- To determine if bromhexine hydrochloride is a useful therapeutic option for pediatric OME.
Main Methods:
- A double-blind, randomized controlled trial was conducted.
- 95 children aged 3-8 years with OME participated.
- Children received two 4-week courses of either bromhexine hydrochloride or placebo.
Main Results:
- 198 ears were in the placebo group and 182 ears in the bromhexine group.
- The resolution rate for the placebo group was 19%.
- The resolution rate for the bromhexine group was 16%.
Conclusions:
- Bromhexine hydrochloride did not demonstrate superior efficacy compared to placebo for OME treatment in children.
- The study suggests bromhexine hydrochloride is not a useful drug for managing OME in this pediatric population.
Abstract:
In a double blind randomised trial of 95 children aged 3-8 years with otitis media with effusion (OME), the efficacy of the mucolytic agent bromhexine hydrochloride (Bisolvon) was compared with a placebo. Each child received two 4 week courses of either bromhexine or placebo in a random fashion. One hundred and ninety ears were available for analysis, i.e. 380 'ear treatments'. There were 198 ears in the placebo group and 182 ears in the bromhexine group. The resolution rate in the placebo treated group was 19% and in the bromhexine treated group 16%. Bromhexine does not appear to be a useful drug for the treatment of OME in children.